<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Hyperlipidemia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Hyperlipidemia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Hyperlipidemia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Hyperlipidemia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Hyperlipidemia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Hyperlipidemia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Hyperlipidemia","wgTitle":"Hyperlipidemia","wgCurRevisionId":670630179,"wgRevisionId":670630179,"wgArticleId":1593643,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Pages containing cite templates with deprecated parameters","Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from October 2014","Articles with unsourced statements from June 2012","Articles that use a Medicine navs subtemplate","Lipid disorders"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Hyperlipidemia","wgRelevantArticleId":1593643,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Hyperlipoproteinemia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Relative_prevalence_of_familial_hyperlipoproteinemias.png/100px-Relative_prevalence_of_familial_hyperlipoproteinemias.png","wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Hyperlipidemia","wgWikibaseItemId":"Q1079120"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Hyperlipidemia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Hyperlipidemia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Hyperlipoproteinemia&amp;redirect=no" title="Hyperlipoproteinemia">Hyperlipoproteinemia</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Hyperlipidemia</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Hyperlipidaemia_-_lipid_in_EDTA_tube.jpg" class="image"><img alt="Hyperlipidaemia - lipid in EDTA tube.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/8d/Hyperlipidaemia_-_lipid_in_EDTA_tube.jpg/230px-Hyperlipidaemia_-_lipid_in_EDTA_tube.jpg" width="230" height="587" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/8d/Hyperlipidaemia_-_lipid_in_EDTA_tube.jpg/345px-Hyperlipidaemia_-_lipid_in_EDTA_tube.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/8d/Hyperlipidaemia_-_lipid_in_EDTA_tube.jpg/460px-Hyperlipidaemia_-_lipid_in_EDTA_tube.jpg 2x" data-file-width="614" data-file-height="1568" /></a>
<div>A 4-ml sample of hyperlipidemic blood with lipids separated into the top fraction (Sample is in an <a href="/wiki/EDTA" title="EDTA" class="mw-redirect">EDTA</a> collection tube.)</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Cardiology" title="Cardiology">Cardiology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/E78">E78</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=272.0">272.0</a>-<a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=272.4">272.4</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb6255.htm">6255</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a rel="nofollow" class="external text" href="http://patient.info/doctor/hyperlipidaemia-pro">Hyperlipidemia</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D006949">D006949</a></td>
</tr>
</table>
<p><b>Hyperlipidemia</b>, <b>hyperlipoproteinemia</b>, or <b>hyperlipidaemia</b> (British English) involves abnormally elevated levels of any or all <a href="/wiki/Lipid" title="Lipid">lipids</a> and/or <a href="/wiki/Lipoprotein" title="Lipoprotein">lipoproteins</a> in the <a href="/wiki/Blood" title="Blood">blood</a>.<sup id="cite_ref-DorlandAndAmericanHeritage_1-0" class="reference"><a href="#cite_note-DorlandAndAmericanHeritage-1"><span>[</span>1<span>]</span></a></sup> It is the most common form of <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> (which includes any abnormal lipid levels).</p>
<p>Lipids (fat-soluble molecules) are transported in a <a href="/wiki/Apolipoprotein" title="Apolipoprotein">protein</a> <a href="/wiki/Lipoprotein" title="Lipoprotein">capsule</a>. The size of that capsule, or <a href="/wiki/Lipoprotein" title="Lipoprotein">lipoprotein</a>, determines its density. The lipoprotein density and type of <a href="/wiki/Apolipoprotein" title="Apolipoprotein">apolipoproteins</a> it contains determines the fate of the particle and its influence on <a href="/wiki/Metabolism" title="Metabolism">metabolism</a>.</p>
<p>Hyperlipidemias are divided into primary and secondary subtypes. Primary hyperlipidemia is usually due to genetic causes (such as a mutation in a receptor protein), while secondary hyperlipidemia arises due to other underlying causes such as <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes</a>. Lipid and lipoprotein abnormalities are common in the general population, and are regarded as a modifiable risk factor for <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> due to their influence on <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>. In addition, some forms may predispose to <a href="/wiki/Acute_pancreatitis" title="Acute pancreatitis">acute pancreatitis</a>.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Familial_.28primary.29"><span class="tocnumber">1.1</span> <span class="toctext">Familial (primary)</span></a>
<ul>
<li class="toclevel-3 tocsection-3"><a href="#Hyperlipoproteinemia_type_I"><span class="tocnumber">1.1.1</span> <span class="toctext">Hyperlipoproteinemia type I</span></a></li>
<li class="toclevel-3 tocsection-4"><a href="#Hyperlipoproteinemia_type_II"><span class="tocnumber">1.1.2</span> <span class="toctext">Hyperlipoproteinemia type II</span></a>
<ul>
<li class="toclevel-4 tocsection-5"><a href="#Type_IIa"><span class="tocnumber">1.1.2.1</span> <span class="toctext">Type IIa</span></a></li>
<li class="toclevel-4 tocsection-6"><a href="#Type_IIb"><span class="tocnumber">1.1.2.2</span> <span class="toctext">Type IIb</span></a></li>
</ul>
</li>
<li class="toclevel-3 tocsection-7"><a href="#Hyperlipoproteinemia_type_III"><span class="tocnumber">1.1.3</span> <span class="toctext">Hyperlipoproteinemia type III</span></a></li>
<li class="toclevel-3 tocsection-8"><a href="#Hyperlipoproteinemia_type_IV"><span class="tocnumber">1.1.4</span> <span class="toctext">Hyperlipoproteinemia type IV</span></a></li>
<li class="toclevel-3 tocsection-9"><a href="#Hyperlipoproteinemia_type_V"><span class="tocnumber">1.1.5</span> <span class="toctext">Hyperlipoproteinemia type V</span></a></li>
<li class="toclevel-3 tocsection-10"><a href="#Unclassified_familial_forms"><span class="tocnumber">1.1.6</span> <span class="toctext">Unclassified familial forms</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-11"><a href="#Acquired_.28secondary.29"><span class="tocnumber">1.2</span> <span class="toctext">Acquired (secondary)</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Management"><span class="tocnumber">2</span> <span class="toctext">Management</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#See_also"><span class="tocnumber">3</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#References"><span class="tocnumber">4</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#External_links"><span class="tocnumber">5</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Hyperlipidemias may basically be classified as either familial (also called primary<sup id="cite_ref-Chait_2-0" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup>) caused by specific genetic abnormalities, or acquired (also called secondary)<sup id="cite_ref-Chait_2-1" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup> when resulting from another underlying disorder that leads to alterations in plasma lipid and lipoprotein metabolism.<sup id="cite_ref-Chait_2-2" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup> Also, hyperlipidemia may be idiopathic, that is, without known cause.</p>
<p>Hyperlipidemias are also classified according to which types of lipids are elevated, that is <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">hypercholesterolemia</a>, <a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">hypertriglyceridemia</a> or both in <a href="/wiki/Combined_hyperlipidemia" title="Combined hyperlipidemia">combined hyperlipidemia</a>. Elevated levels of <a href="/wiki/Lipoprotein(a)" title="Lipoprotein(a)">Lipoprotein(a)</a> may also be classified as a form of hyperlipidemia.</p>
<h3><span class="mw-headline" id="Familial_.28primary.29">Familial (primary)</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=2" title="Edit section: Familial (primary)">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Familial hyperlipidemias are classified according to the <a href="/wiki/Donald_S._Fredrickson" title="Donald S. Fredrickson">Fredrickson</a> classification, which is based on the pattern of lipoproteins on <a href="/wiki/Electrophoresis" title="Electrophoresis">electrophoresis</a> or <a href="/wiki/Ultracentrifuge" title="Ultracentrifuge">ultracentrifugation</a>.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup> It was later adopted by the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO). It does not directly account for <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein" class="mw-redirect">HDL</a>, and it does not distinguish among the different <a href="/wiki/Genes" title="Genes" class="mw-redirect">genes</a> that may be partially responsible for some of these conditions.</p>
<table class="sortable wikitable">
<caption><b>Fredrickson classification of hyperlipidemias</b></caption>
<tr>
<th colspan="2">Hyperlipo-<br />
proteinemia</th>
<th><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<th>Synonyms</th>
<th>Defect</th>
<th>Increased lipoprotein</th>
<th>Main symptoms</th>
<th>Treatment</th>
<th>Serum appearance</th>
<th>Estimated prevalence</th>
</tr>
<tr>
<th rowspan="3"><a href="/wiki/Type_I_hyperlipoproteinemia" title="Type I hyperlipoproteinemia" class="mw-redirect">Type I</a></th>
<th><a href="/wiki/Hyperlipoproteinemia_type_Ia" title="Hyperlipoproteinemia type Ia" class="mw-redirect">a</a></th>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/238600">238600</a></td>
<td>Buerger-Gruetz syndrome or familial hyperchylomicronemia</td>
<td>Decreased <a href="/wiki/Lipoprotein_lipase" title="Lipoprotein lipase">lipoprotein lipase</a> (LPL)</td>
<td rowspan="3"><a href="/wiki/Chylomicrons" title="Chylomicrons" class="mw-redirect">Chylomicrons</a></td>
<td rowspan="3"><a href="/wiki/Acute_pancreatitis" title="Acute pancreatitis">Acute pancreatitis</a>, <a href="/wiki/Lipemia_retinalis" title="Lipemia retinalis" class="mw-redirect">lipemia retinalis</a>, eruptive skin <a href="/wiki/Xanthoma" title="Xanthoma">xanthomas</a>, <a href="/wiki/Hepatosplenomegaly" title="Hepatosplenomegaly">hepatosplenomegaly</a></td>
<td rowspan="3">Diet control</td>
<td rowspan="3">Creamy top layer</td>
<td rowspan="3">One in 1,000,000<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup></td>
</tr>
<tr>
<th><a href="/wiki/Hyperlipoproteinemia_type_Ib" title="Hyperlipoproteinemia type Ib" class="mw-redirect">b</a></th>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/207750">207750</a></td>
<td>Familial apoprotein CII deficiency</td>
<td>Altered <a href="/wiki/Apolipoprotein_C2" title="Apolipoprotein C2">ApoC2</a></td>
</tr>
<tr>
<th><a href="/wiki/Hyperlipoproteinemia_type_Ic" title="Hyperlipoproteinemia type Ic" class="mw-redirect">c</a></th>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/118830">118830</a></td>
<td></td>
<td><a href="/wiki/Lipoprotein_lipase" title="Lipoprotein lipase">LPL</a> inhibitor in blood</td>
</tr>
<tr>
<th rowspan="2">Type II</th>
<th>a</th>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/143890">143890</a></td>
<td><a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">Familial hypercholesterolemia</a></td>
<td><a href="/wiki/LDL_receptor" title="LDL receptor">LDL receptor</a> deficiency</td>
<td><a href="/wiki/LDL" title="LDL" class="mw-redirect">LDL</a></td>
<td><a href="/wiki/Xanthelasma" title="Xanthelasma">Xanthelasma</a>, <a href="/wiki/Arcus_senilis" title="Arcus senilis">arcus senilis</a>, tendon xanthomas</td>
<td><a href="/wiki/Bile_acid_sequestrant" title="Bile acid sequestrant">Bile acid sequestrants</a>, <a href="/wiki/Statin" title="Statin">statins</a>, <a href="/wiki/Niacin" title="Niacin">niacin</a></td>
<td>Clear</td>
<td>One in 500 for heterozygotes</td>
</tr>
<tr>
<th>b</th>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/144250">144250</a></td>
<td>Familial combined hyperlipidemia</td>
<td>Decreased <a href="/wiki/LDL_receptor" title="LDL receptor">LDL receptor</a> and increased <a href="/wiki/Apolipoprotein_B" title="Apolipoprotein B">ApoB</a></td>
<td><a href="/wiki/LDL" title="LDL" class="mw-redirect">LDL</a> and <a href="/wiki/VLDL" title="VLDL" class="mw-redirect">VLDL</a></td>
<td></td>
<td>Statins, <a href="/wiki/Niacin" title="Niacin">niacin</a>, <a href="/wiki/Fibrate" title="Fibrate">fibrate</a></td>
<td>Clear</td>
<td>1 in 100</td>
</tr>
<tr>
<th colspan="2">Type III</th>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/107741">107741</a></td>
<td><a href="/wiki/Familial_dysbetalipoproteinemia" title="Familial dysbetalipoproteinemia">Familial dysbetalipoproteinemia</a></td>
<td>Defect in <a href="/wiki/Apolipoprotein_E" title="Apolipoprotein E">Apo E 2</a> synthesis</td>
<td><a href="/wiki/Intermediate_density_lipoprotein" title="Intermediate density lipoprotein" class="mw-redirect">IDL</a></td>
<td>Tuboeruptive xanthomas and palmar xanthomas</td>
<td>Fibrate, statins</td>
<td>Turbid</td>
<td>One in 10,000<sup id="cite_ref-fung2011_5-0" class="reference"><a href="#cite_note-fung2011-5"><span>[</span>5<span>]</span></a></sup></td>
</tr>
<tr>
<th colspan="2">Type IV</th>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/144600">144600</a></td>
<td><a href="/wiki/Familial_hypertriglyceridemia" title="Familial hypertriglyceridemia">Familial hypertriglyceridemia</a></td>
<td>Increased VLDL production and decreased elimination</td>
<td>VLDL</td>
<td>Can cause <a href="/wiki/Pancreatitis" title="Pancreatitis">pancreatitis</a> at high triglyceride levels</td>
<td>Fibrate, niacin, statins</td>
<td>Turbid</td>
<td>One in 100</td>
</tr>
<tr>
<th colspan="2"><a href="#type_V">Type V</a></th>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/144650">144650</a></td>
<td></td>
<td>Increased VLDL production and decreased <a href="/wiki/Lipoprotein_lipase" title="Lipoprotein lipase">LPL</a></td>
<td>VLDL and chylomicrons</td>
<td></td>
<td>Niacin, fibrate</td>
<td>Creamy top layer and turbid bottom</td>
<td></td>
</tr>
</table>
<div class="center">
<div class="thumb tnone">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Relative_prevalence_of_familial_hyperlipoproteinemias.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Relative_prevalence_of_familial_hyperlipoproteinemias.png/220px-Relative_prevalence_of_familial_hyperlipoproteinemias.png" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Relative_prevalence_of_familial_hyperlipoproteinemias.png/330px-Relative_prevalence_of_familial_hyperlipoproteinemias.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Relative_prevalence_of_familial_hyperlipoproteinemias.png/440px-Relative_prevalence_of_familial_hyperlipoproteinemias.png 2x" data-file-width="766" data-file-height="576" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Relative_prevalence_of_familial_hyperlipoproteinemias.png" class="internal" title="Enlarge"></a></div>
Relative prevalence of familial forms of hyperlipoproteinemia<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup></div>
</div>
</div>
</div>
<h4><span class="mw-headline" id="Hyperlipoproteinemia_type_I">Hyperlipoproteinemia type I</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=3" title="Edit section: Hyperlipoproteinemia type I">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><span id="type_I"></span> Type I hyperlipoproteinemia exists in several forms:</p>
<ul>
<li><a href="/wiki/Lipoprotein_lipase_deficiency" title="Lipoprotein lipase deficiency">Lipoprotein lipase deficiency (type Ia)</a>, due to a deficiency of <a href="/wiki/Lipoprotein_lipase" title="Lipoprotein lipase">lipoprotein lipase</a> (LPL) or altered <a href="/wiki/Apolipoprotein_C2" title="Apolipoprotein C2">apolipoprotein C2</a>, resulting in elevated <a href="/wiki/Chylomicron" title="Chylomicron">chylomicrons</a>, the particles that transfer fatty acids from the <a href="/wiki/Digestive_tract" title="Digestive tract" class="mw-redirect">digestive tract</a> to the <a href="/wiki/Liver" title="Liver">liver</a></li>
<li>Familial apoprotein CII deficiency (type Ib),<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup> a condition caused by a lack of lipoprotein lipase activator.<sup id="cite_ref-Andrews_9-0" class="reference"><a href="#cite_note-Andrews-9"><span>[</span>9<span>]</span></a></sup><sup class="reference" style="white-space:nowrap;">:533</sup></li>
<li>Chylomicronemia due to circulating inhibitor of lipoprotein lipase (type Ic)<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup></li>
</ul>
<p>Type I hyperlipoproteinemia usually presents in childhood with eruptive xanthomata and abdominal colic. Complications include retinal vein occlusion, acute pancreatitis, steatosis and organomegaly, and lipaemia retinalis.</p>
<h4><span class="mw-headline" id="Hyperlipoproteinemia_type_II">Hyperlipoproteinemia type II</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=4" title="Edit section: Hyperlipoproteinemia type II">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Hyperlipoproteinemia type II, by far the most common form, is further classified into types IIa and IIb, depending mainly on whether elevation in the triglyceride level occurs in addition to LDL cholesterol.</p>
<h5><span class="mw-headline" id="Type_IIa">Type IIa</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=5" title="Edit section: Type IIa">edit</a><span class="mw-editsection-bracket">]</span></span></h5>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">Familial hypercholesterolemia</a></div>
<p>This may be sporadic (due to dietary factors), polygenic, or truly familial as a result of a mutation either in the <a href="/wiki/LDL_receptor" title="LDL receptor">LDL receptor</a> gene on <a href="/wiki/Chromosome_19" title="Chromosome 19" class="mw-redirect">chromosome 19</a> (0.2% of the population) or the <a href="/wiki/Apolipoprotein_B" title="Apolipoprotein B">ApoB</a> gene (0.2%). The familial form is characterized by <a href="/wiki/Xanthoma" title="Xanthoma">tendon xanthoma</a>, <a href="/wiki/Xanthelasma" title="Xanthelasma">xanthelasma</a>, and premature cardiovascular disease. The incidence of this disease is about one in 500 for heterozygotes, and one in 1,000,000 for homozygotes.</p>
<p>HLPIIa is a rare genetic disorder characterized by increased levels of LDL cholesterol in the blood due to the lack of uptake (no Apo B receptors) of LDL particles. This pathology, however, is the second-most common disorder of the various hyperlipoproteinemias, with individuals with a heterozygotic predisposition of one in every 500 and individuals with homozygotic predisposition of one in every million. These individuals may present with a unique set of physical characteristics such as: xanthelasmas (yellow deposits of fat underneath the skin often presenting in the nasal portion of the eye), tendon and tuberous xanthomas, arcus juvenilis (the graying of the eye often characterized in older individuals), arterial bruits, claudication, and of course atherosclerosis. Laboratory findings for these individuals are obvious and yet interesting because their serum cholesterol levels are two to three times greater than normal, as well as increased LDL cholesterol, but their triglycerides and VLDL values fall in the normal ranges. To manage persons with HLPIIa, drastic measures may need to be taken, especially if their HDL cholesterol levels are less than 30&#160;mg/dl and their LDL levels are greater than 160&#160;mg/dl. A proper diet for these individuals requires a decrease in total fat to less than 30% of total calories with a ratio of monounsaturated:polyunsaturated:saturated fat of 1:1:1. Cholesterol should be reduced to less than 300&#160;mg/day, thus the avoidance of animal products and to increase fiber intake to more than 20 g/day with 6g of soluble fiber/day.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2014)">citation needed</span></a></i>]</sup> Exercise should be promoted, as it can increase HDL. The overall prognosis for these individuals is in the worst-case scenario if uncontrolled and untreated individuals may die before the age of 20, but if one seeks a prudent diet with correct medical intervention, the individual may see an increased incidence of xanthomas with each decade, and Achilles tendinitis and accelerated atherosclerosis will occur.</p>
<h5><span class="mw-headline" id="Type_IIb">Type IIb</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=6" title="Edit section: Type IIb">edit</a><span class="mw-editsection-bracket">]</span></span></h5>
<p>The high VLDL levels are due to overproduction of substrates, including triglycerides, acetyl CoA, and an increase in B-100 synthesis. They may also be caused by the decreased clearance of LDL. Prevalence in the population is 10%.</p>
<ul>
<li>Familial combined hyperlipoproteinemia (FCH)</li>
<li><a href="/wiki/Lysosomal_acid_lipase_deficiency" title="Lysosomal acid lipase deficiency">Lysosomal acid lipase deficiency</a>, often called (<a href="/wiki/Cholesteryl_ester_storage_disease" title="Cholesteryl ester storage disease">Cholesteryl ester storage disease</a>)</li>
<li>Secondary combined hyperlipoproteinemia (usually in the context of <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a>, for which it is a diagnostic criterion)</li>
</ul>
<h4><span class="mw-headline" id="Hyperlipoproteinemia_type_III">Hyperlipoproteinemia type III</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=7" title="Edit section: Hyperlipoproteinemia type III">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>This form is due to high <a href="/wiki/Chylomicron" title="Chylomicron">chylomicrons</a> and IDL (intermediate density lipoprotein). Also known as <i>broad beta disease</i> or <i>dysbetalipoproteinemia</i>, the most common cause for this form is the presence of <a href="/wiki/Apolipoprotein_E" title="Apolipoprotein E">ApoE</a> E2/E2 genotype. It is due to cholesterol-rich VLDL (β-VLDL). Its prevalence has been estimated to be approximately 1 in 10,000.<sup id="cite_ref-fung2011_5-1" class="reference"><a href="#cite_note-fung2011-5"><span>[</span>5<span>]</span></a></sup></p>
<p>It is associated with hypercholesterolaemia (typically 8-12&#160;mmol/L), hypertriglyceridaemia (typically 5-20&#160;mmol/L), a normal ApoB concentration, and two types of skin signs (palmar xanthomata or orange discoloration of skin creases, and tuberoeruptive xanthomata on the elbows and knees). It is characterized by the early onset of cardiovascular disease and peripheral vascular disease. Remnant hyperlipidaemia occurs as a result of abnormal function of the ApoE receptor, which is normally required for clearance of chylomicron remnants and IDL from the circulation. The receptor defect causes levels of chylomicron remnants and IDL to be higher than normal in the blood stream. The receptor defect is an autosomal recessive mutation or polymorphism.</p>
<h4><span class="mw-headline" id="Hyperlipoproteinemia_type_IV">Hyperlipoproteinemia type IV</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=8" title="Edit section: Hyperlipoproteinemia type IV">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Familial_hypertriglyceridemia" title="Familial hypertriglyceridemia">Familial hypertriglyceridemia</a> is an autosomal dominant condition occurring in approximately 1% of the population.<sup id="cite_ref-Boman1975_11-0" class="reference"><a href="#cite_note-Boman1975-11"><span>[</span>11<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Hyperlipoproteinemia_type_V">Hyperlipoproteinemia type V</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=9" title="Edit section: Hyperlipoproteinemia type V">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><span id="type_V"></span>Hyperlipoproteinemia type V, also known as mixed hyperlipoproteinemia familial or mixed hyperlipidemia,<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> is very similar to type I, but with high <a href="/wiki/VLDL" title="VLDL" class="mw-redirect">VLDL</a> in addition to chylomicrons.</p>
<p>It is also associated with glucose intolerance and hyperuricemia</p>
<p>In medicine, combined hyperlipidemia (or -aemia) (also known as "multiple-type hyperlipoproteinemia") is a commonly occurring form of hypercholesterolemia (elevated cholesterol levels) characterised by increased LDL and triglyceride concentrations, often accompanied by decreased HDL.<sup id="cite_ref-Elsevier_13-0" class="reference"><a href="#cite_note-Elsevier-13"><span>[</span>13<span>]</span></a></sup> On lipoprotein electrophoresis (a test now rarely performed) it shows as a hyperlipoproteinemia type IIB. It is the most common inherited lipid disorder, occurring in about one in 200 persons. In fact, almost one in five individuals who develop coronary heart disease before the age of 60 have this disorder. The elevated triglyceride levels (&gt;5&#160;mmol/l) are generally due to an increase in very low density lipoprotein (VLDL), a class of lipoprotein prone to cause atherosclerosis.</p>
<p>Types</p>
<ol>
<li>Familial combined hyperlipidemia (FCH) is the familial occurrence of this disorder, probably caused by decreased LDL receptor and increased ApoB.</li>
<li>FCH is extremely common in patients who suffer from other diseases from the metabolic syndrome ("syndrome X", incorporating diabetes mellitus type II, hypertension, central obesity and CH). Excessive free fatty acid production by various tissues leads to increased VLDL synthesis by the liver. Initially, most VLDL is converted into LDL until this mechanism is saturated, after which VLDL levels elevate.</li>
</ol>
<p>Both conditions are treated with fibrate drugs, which act on the peroxisome proliferator-activated receptors (PPARs), specifically PPARα, to decrease free fatty acid production. Statin drugs, especially the synthetic statins (atorvastatin and rosuvastatin) can decrease LDL levels by increasing hepatic reuptake of LDL due to increased LDL-receptor expression.</p>
<h4><span class="mw-headline" id="Unclassified_familial_forms">Unclassified familial forms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=10" title="Edit section: Unclassified familial forms">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>These unclassified forms are extremely rare:</p>
<ul>
<li><a href="/w/index.php?title=Hyperalphalipoproteinemia&amp;action=edit&amp;redlink=1" class="new" title="Hyperalphalipoproteinemia (page does not exist)">Hyperalphalipoproteinemia</a></li>
<li><a href="/wiki/Polygenic_hypercholesterolemia" title="Polygenic hypercholesterolemia" class="mw-redirect">Polygenic hypercholesterolemia</a></li>
</ul>
<h3><span class="mw-headline" id="Acquired_.28secondary.29">Acquired (secondary)</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=11" title="Edit section: Acquired (secondary)">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Acquired hyperlipidemias (also called secondary dyslipoproteinemias) often mimic primary forms of hyperlipidemia and can have similar consequences.<sup id="cite_ref-Chait_2-3" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup> They may result in increased risk of premature <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a> or, when associated with marked <a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">hypertriglyceridemia</a>, may lead to <a href="/wiki/Pancreatitis" title="Pancreatitis">pancreatitis</a> and other complications of the <a href="/wiki/Chylomicronemia_syndrome" title="Chylomicronemia syndrome" class="mw-redirect">chylomicronemia syndrome</a>.<sup id="cite_ref-Chait_2-4" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup> The most common causes of acquired hyperlipidemia are:</p>
<ul>
<li><a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes mellitus</a><sup id="cite_ref-Chait_2-5" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup></li>
<li>Use of drugs such as <a href="/wiki/Thiazide_diuretics" title="Thiazide diuretics" class="mw-redirect">thiazide diuretics</a>,<sup id="cite_ref-Chait_2-6" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup> <a href="/wiki/Beta_blockers" title="Beta blockers" class="mw-redirect">beta blockers</a>,<sup id="cite_ref-Chait_2-7" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup> and <a href="/wiki/Estrogens" title="Estrogens" class="mw-redirect">estrogens</a><sup id="cite_ref-Chait_2-8" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup></li>
</ul>
<p>Other conditions leading to acquired hyperlipidemia include:</p>
<ul>
<li>Hypothyroidism<sup id="cite_ref-Chait_2-9" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup></li>
<li><a href="/wiki/Renal_failure" title="Renal failure">Renal failure</a><sup id="cite_ref-Chait_2-10" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup></li>
<li><a href="/wiki/Nephrotic_syndrome" title="Nephrotic syndrome">Nephrotic syndrome</a><sup id="cite_ref-Chait_2-11" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup></li>
<li><a href="/wiki/Alcohol_consumption" title="Alcohol consumption" class="mw-redirect">Alcohol consumption</a><sup id="cite_ref-Chait_2-12" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup></li>
<li>Some rare <a href="/wiki/Endocrine_disorder" title="Endocrine disorder" class="mw-redirect">endocrine disorders</a><sup id="cite_ref-Chait_2-13" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup> and <a href="/wiki/Metabolic_disorders" title="Metabolic disorders">metabolic disorders</a><sup id="cite_ref-Chait_2-14" class="reference"><a href="#cite_note-Chait-2"><span>[</span>2<span>]</span></a></sup></li>
</ul>
<p>Treatment of the underlying condition, when possible, or discontinuation of the offending drugs usually leads to an improvement in the hyperlipidemia. Specific lipid-lowering therapy may be required in certain circumstances.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (June 2012)">citation needed</span></a></i>]</sup></p>
<p>Another acquired cause of hyperlipidemia, although not always included in this category, is postprandial hyperlipidemia, a normal increase following ingestion of food.<sup id="cite_ref-Elsevier_13-1" class="reference"><a href="#cite_note-Elsevier-13"><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-BioMed_Central_14-0" class="reference"><a href="#cite_note-BioMed_Central-14"><span>[</span>14<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=12" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>For treatment of type II, dietary modification is the initial approach, but many patients require treatment with <a href="/wiki/Statin" title="Statin">statins</a> (HMG-CoA reductase inhibitors) to reduce cardiovascular risk. If the triglyceride level is markedly raised, <a href="/wiki/Fibrate" title="Fibrate">fibrates</a> (peroxisome proliferator-activated receptor-alpha agonists) may be preferable due to their beneficial effects. Combination treatment of statins and fibrates, while highly effective, causes a markedly increased risk of <a href="/wiki/Myopathy" title="Myopathy">myopathy</a> and <a href="/wiki/Rhabdomyolysis" title="Rhabdomyolysis">rhabdomyolysis</a>, so is only done under close supervision. Other agents commonly added to statins are <a href="/wiki/Ezetimibe" title="Ezetimibe">ezetimibe</a>, <a href="/wiki/Niacin" title="Niacin">niacin</a>, and <a href="/wiki/Bile_acid_sequestrant" title="Bile acid sequestrant">bile acid sequestrants</a>. Dietary supplementation with fish oil is also used to reduce elevated triglycerides, with the greatest effect occurring in patients with the greatest severity.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> Some evidence exists for benefit of plant sterol-containing products and <a href="/wiki/Omega-3_fatty_acid" title="Omega-3 fatty acid">omega-3 fatty acids</a>.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=13" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/List_of_xanthoma_variants_associated_with_hyperlipoproteinemia_subtypes" title="List of xanthoma variants associated with hyperlipoproteinemia subtypes">List of xanthoma variants associated with hyperlipoproteinemia subtypes</a></li>
<li><a href="/wiki/Combined_hyperlipidemia" title="Combined hyperlipidemia">Combined hyperlipidemia</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=14" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-DorlandAndAmericanHeritage-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-DorlandAndAmericanHeritage_1-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://medical-dictionary.thefreedictionary.com/hyperlipidemia">thefreedictionary.com &gt; hyperlipidemia</a> Citing:</span>
<ul>
<li><span class="reference-text">Dorland's Medical Dictionary for Health Consumers. 2007 by Saunders, an imprint of Elsevier</span></li>
<li><span class="reference-text">The American Heritage Medical Dictionary. 2007, 2004 by Houghton Mifflin Company.</span></li>
</ul>
</li>
<li id="cite_note-Chait-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Chait_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Chait_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Chait_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Chait_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Chait_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Chait_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Chait_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Chait_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Chait_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Chait_2-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Chait_2-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Chait_2-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Chait_2-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Chait_2-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Chait_2-14"><sup><i><b>o</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Chait A, Brunzell JD (June 1990). "Acquired hyperlipidemia (secondary dyslipoproteinemias)". <i>Endocrinol. Metab. Clin. North Am.</i> <b>19</b> (2): 259–78. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2192873">2192873</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHyperlipidemia&amp;rft.atitle=Acquired+hyperlipidemia+%28secondary+dyslipoproteinemias%29&amp;rft.au=Chait+A%2C+Brunzell+JD&amp;rft.aulast=Chait+A%2C+Brunzell+JD&amp;rft.date=June+1990&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2192873&amp;rft.issue=2&amp;rft.jtitle=Endocrinol.+Metab.+Clin.+North+Am.&amp;rft.pages=259-78&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation journal">Fredrickson, DS; Lees, RS (1965). <a rel="nofollow" class="external text" href="http://circ.ahajournals.org/cgi/reprint/31/3/321">"A system for phenotyping hyperlipoproteinemia"</a> <span style="font-size:85%;">(PDF)</span>. <i>Circulation</i> <b>31</b> (3): 321–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.CIR.31.3.321">10.1161/01.CIR.31.3.321</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14262568">14262568</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHyperlipidemia&amp;rft.atitle=A+system+for+phenotyping+hyperlipoproteinemia&amp;rft.aufirst=DS&amp;rft.au=Fredrickson%2C+DS&amp;rft.aulast=Fredrickson&amp;rft.au=Lees%2C+RS&amp;rft.date=1965&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Freprint%2F31%2F3%2F321&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.31.3.321&amp;rft_id=info%3Apmid%2F14262568&amp;rft.issue=3&amp;rft.jtitle=Circulation&amp;rft.pages=321-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.cags.org.ae/FMPro?-DB=ctga.fp5&amp;-Format=ctga/ctga_detail.html&amp;-RecID=34563&amp;-Find">Hyperlipoproteinemia, Type I</a> from Centre for Arab Genomic Studies. Retrieved July 2011. Citing: "About 1:1,000,000 people are affected with Hyperlipoproteinemia type I worldwide with a higher prevalence in some regions of Canada."</span></li>
<li id="cite_note-fung2011-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-fung2011_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-fung2011_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Fung, M.; Hill, J.; Cook, D.; Frohlich, J. (2011). "Case series of type III hyperlipoproteinemia in children". <i>Case Reports</i> <b>2011</b>: bcr0220113895. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbcr.02.2011.3895">10.1136/bcr.02.2011.3895</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHyperlipidemia&amp;rft.atitle=Case+series+of+type+III+hyperlipoproteinemia+in+children&amp;rft.au=Cook%2C+D.&amp;rft.aufirst=M.&amp;rft.au=Frohlich%2C+J.&amp;rft.au=Fung%2C+M.&amp;rft.au=Hill%2C+J.&amp;rft.aulast=Fung&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fbcr.02.2011.3895&amp;rft.jtitle=Case+Reports&amp;rft.pages=bcr0220113895&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2011" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.pharmacist.com/AM/Template.cfm?Section=Home2&amp;CONTENTID=14388&amp;TEMPLATE=/CM/ContentDisplay.cfm">New Product Bulletin on Crestor® (rosuvastatin)</a></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://omim.org/entry/207750">OMIM entry 207750</a> last updated 02/10/2009</span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation journal">Yamamura, T.; Sudo, H.; Ishikawa, K.; Yamamoto, A. (1979). "Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency". <i>Atherosclerosis</i> <b>34</b> (1): 53–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0021-9150%2879%2990106-0">10.1016/0021-9150(79)90106-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/227429">227429</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHyperlipidemia&amp;rft.atitle=Familial+type+I+hyperlipoproteinemia+caused+by+apolipoprotein+C-II+deficiency&amp;rft.aufirst=T.&amp;rft.au=Ishikawa%2C+K.&amp;rft.aulast=Yamamura&amp;rft.au=Sudo%2C+H.&amp;rft.au=Yamamoto%2C+A.&amp;rft.au=Yamamura%2C+T.&amp;rft.date=1979&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0021-9150%2879%2990106-0&amp;rft_id=info%3Apmid%2F227429&amp;rft.issue=1&amp;rft.jtitle=Atherosclerosis&amp;rft.pages=53-65&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Andrews-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-Andrews_9-0">^</a></b></span> <span class="reference-text"><span class="citation book">James, William D.; Berger, Timothy G.; et al. (2006). <i>Andrews' Diseases of the Skin: clinical Dermatology</i>. Saunders Elsevier. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7216-2921-0" title="Special:BookSources/0-7216-2921-0">0-7216-2921-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHyperlipidemia&amp;rft.au=James%2C+William+D.%3B+Berger%2C+Timothy+G.%3B&amp;rft.aulast=James%2C+William+D.%3B+Berger%2C+Timothy+G.%3B&amp;rft.btitle=Andrews%27+Diseases+of+the+Skin%3A+clinical+Dermatology&amp;rft.date=2006&amp;rft.genre=book&amp;rft.isbn=0-7216-2921-0&amp;rft.pub=Saunders+Elsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://omim.org/entry/118830">OMIM entry 118830</a> updated 03/18/2004</span></li>
<li id="cite_note-Boman1975-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Boman1975_11-0">^</a></b></span> <span class="reference-text">Boman H, Hazzard WR, AlbersJJ, et ah Frequency of monogenic forms of hyperlipidemia in a normal population. AmJ ttum Genet 27:19A,1975. <a rel="nofollow" class="external autonumber" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762895/pdf/ajhg00439-0130.pdf">[1]</a></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.medilexicon.com/medicaldictionary.php?s=type+5+hyperlipidemia">"Medical Definition Search For 'Type 5 Hyperlipidemia"</a>. medilexicon<span class="reference-accessdate">. Retrieved <span class="nowrap">1 November</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHyperlipidemia&amp;rft.btitle=Medical+Definition+Search+For+%27Type+5+Hyperlipidemia&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.medilexicon.com%2Fmedicaldictionary.php%3Fs%3Dtype%2B5%2Bhyperlipidemia&amp;rft.pub=medilexicon&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Elsevier-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Elsevier_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Elsevier_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://medical-dictionary.thefreedictionary.com/hyperlipidemia">thefreedictionary.com &gt; hyperlipidemia</a> Citing:</span>
<ul>
<li><span class="reference-text">Saunders Comprehensive Veterinary Dictionary, 3 ed. 2007 by Elsevier</span></li>
</ul>
</li>
<li id="cite_note-BioMed_Central-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-BioMed_Central_14-0">^</a></b></span> <span class="reference-text"><span class="citation news">Sameer Ansar; Juraj Koska; Peter D Reaven. <a rel="nofollow" class="external text" href="http://www.cardiab.com/content/10/1/61">"Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: Role of Incretins"</a>. <i>Cardiovascular Diabetology</i></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHyperlipidemia&amp;rft.atitle=Postprandial+hyperlipidemia%2C+endothelial+dysfunction+and+cardiovascular+risk%3A+Role+of+Incretins&amp;rft.au=Juraj+Koska&amp;rft.aulast=Sameer+Ansar&amp;rft.au=Peter+D+Reaven&amp;rft.au=Sameer+Ansar&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cardiab.com%2Fcontent%2F10%2F1%2F61&amp;rft.jtitle=Cardiovascular+Diabetology&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|separator=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text">Mattar M, Obeid O. Fish oil and the management of hypertriglyceridemia. Nutr Health. 2009;20(1):41-9.</span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Thompson, GR (2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1768388">"Management of dyslipidaemia"</a>. <i>Heart (British Cardiac Society)</i> <b>90</b> (8): 949–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fhrt.2003.021287">10.1136/hrt.2003.021287</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1768388">1768388</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15253984">15253984</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHyperlipidemia&amp;rft.atitle=Management+of+dyslipidaemia&amp;rft.aufirst=GR&amp;rft.aulast=Thompson&amp;rft.au=Thompson%2C+GR&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1768388&amp;rft_id=info%3Adoi%2F10.1136%2Fhrt.2003.021287&amp;rft_id=info%3Apmc%2F1768388&amp;rft_id=info%3Apmid%2F15253984&amp;rft.issue=8&amp;rft.jtitle=Heart+%28British+Cardiac+Society%29&amp;rft.pages=949-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=90" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit&amp;section=15" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://profiles.nlm.nih.gov/FF/Views/Exhibit/visuals/scientist.html">The Fredrickson papers (with photos from early lipoprotein research)</a></li>
<li><i><a rel="nofollow" class="external text" href="http://www.gpnotebook.co.uk/simplepage.cfm?ID=745209914">745209914</a></i> at <a href="/wiki/GPnotebook" title="GPnotebook">GPnotebook</a></li>
<li><a rel="nofollow" class="external text" href="http://www.radcliffecardiology.com/prevention-risk/hyperlipidemia">Hyperlipidemia (Radcliffe Cardiology)</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lipid_metabolism_disorders" title="Template:Lipid metabolism disorders"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lipid_metabolism_disorders" title="Template talk:Lipid metabolism disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lipid_metabolism_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">Inborn error</a> of <a href="/wiki/Inborn_error_of_lipid_metabolism" title="Inborn error of lipid metabolism">lipid metabolism</a>: <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#.28E75.29_Lipids" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E78</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Other_metabolic_and_immunity_disorders_.28270.E2.80.93279.29" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">272.0–272.6</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><strong class="selflink">Hyperlipidemia</strong></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">Hypercholesterolemia</a>/<a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">Hypertriglyceridemia</a>
<ul>
<li><a href="/wiki/Lipoprotein_lipase_deficiency" title="Lipoprotein lipase deficiency">Lipoprotein lipase deficiency/Type Ia</a></li>
<li><a href="/wiki/Familial_apoprotein_CII_deficiency" title="Familial apoprotein CII deficiency" class="mw-redirect">Familial apoprotein CII deficiency/Type Ib</a></li>
<li><a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">Familial hypercholesterolemia/Type IIa</a></li>
<li><a href="/wiki/Combined_hyperlipidemia" title="Combined hyperlipidemia">Combined hyperlipidemia/Type IIb</a></li>
<li><a href="/wiki/Familial_dysbetalipoproteinemia" title="Familial dysbetalipoproteinemia">Familial dysbetalipoproteinemia/Type III</a></li>
<li><a href="/wiki/Familial_hypertriglyceridemia" title="Familial hypertriglyceridemia">Familial hypertriglyceridemia/Type IV</a></li>
</ul>
</li>
<li><a href="/wiki/Xanthoma" title="Xanthoma">Xanthoma/Xanthomatosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypolipoproteinemia" title="Hypolipoproteinemia">Hypolipoproteinemia</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypoalphalipoproteinemia" title="Hypoalphalipoproteinemia">Hypoalphalipoproteinemia/HDL</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lecithin_cholesterol_acyltransferase_deficiency" title="Lecithin cholesterol acyltransferase deficiency">Lecithin cholesterol acyltransferase deficiency</a></li>
<li><a href="/wiki/Tangier_disease" title="Tangier disease">Tangier disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypobetalipoproteinemia" title="Hypobetalipoproteinemia">Hypobetalipoproteinemia/LDL</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Abetalipoproteinemia" title="Abetalipoproteinemia">Abetalipoproteinemia</a></li>
<li><a href="/wiki/Apolipoprotein_B_deficiency" title="Apolipoprotein B deficiency">Apolipoprotein B deficiency</a></li>
<li><a href="/wiki/Chylomicron_retention_disease" title="Chylomicron retention disease">Chylomicron retention disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lipodystrophy" title="Lipodystrophy">Lipodystrophy</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Barraquer%E2%80%93Simons_syndrome" title="Barraquer–Simons syndrome">Barraquer–Simons syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lipomatosis" title="Lipomatosis">Lipomatosis</a></li>
<li><a href="/wiki/Adiposis_dolorosa" title="Adiposis dolorosa">Adiposis dolorosa</a></li>
<li><a href="/wiki/Urbach%E2%80%93Wiethe_disease" title="Urbach–Wiethe disease">Lipoid proteinosis</a></li>
<li><a href="/wiki/Familial_renal_amyloidosis" title="Familial renal amyloidosis">APOA1 familial renal amyloidosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Metabolic_navs" title="Template:Metabolic navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Metabolic_navs" title="Template talk:Metabolic navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Metabolic_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">inborn errors of metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolism" title="Template:Metabolism">Metabolism</a></li>
<li>Enzymes and pathways: <a href="/wiki/Template:Citric_acid_cycle" title="Template:Citric acid cycle">citric acid cycle</a>
<ul>
<li><a href="/wiki/Template:Citric_acid_cycle_enzymes_and_ETC" title="Template:Citric acid cycle enzymes and ETC">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_enzymes" title="Template:Pentose phosphate pathway enzymes">pentose phosphate</a>
<ul>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_intermediates" title="Template:Pentose phosphate pathway intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycoproteins" title="Template:Glycoproteins">glycoproteins</a>
<ul>
<li><a href="/wiki/Template:Glycoprotein_metabolism_enzymes" title="Template:Glycoprotein metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycosaminoglycans" title="Template:Glycosaminoglycans">glycosaminoglycans</a>
<ul>
<li><a href="/wiki/Template:Proteoglycan_metabolism_enzymes" title="Template:Proteoglycan metabolism enzymes">proteoglycan enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Phospholipids" title="Template:Phospholipids">phospholipid</a>
<ul>
<li><a href="/wiki/Template:Phospholipid_metabolism" title="Template:Phospholipid metabolism">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cholesterol_and_steroid_metabolism_enzymes" title="Template:Cholesterol and steroid metabolism enzymes">cholesterol and steroid</a>
<ul>
<li><a href="/wiki/Template:Cholesterol_and_steroid_intermediates" title="Template:Cholesterol and steroid intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Sphingolipids" title="Template:Sphingolipids">sphingolipids</a>
<ul>
<li><a href="/wiki/Template:Glycolipid/sphingolipid_metabolism_enzymes" title="Template:Glycolipid/sphingolipid metabolism enzymes" class="mw-redirect">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Eicosanoids" title="Template:Eicosanoids">eicosanoids</a>
<ul>
<li><a href="/wiki/Template:Eicosanoid_metabolism_enzymes" title="Template:Eicosanoid metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Amino_acid_metabolism_enzymes" title="Template:Amino acid metabolism enzymes">amino acid</a>
<ul>
<li><a href="/wiki/Template:Amino_acid_metabolism_intermediates" title="Template:Amino acid metabolism intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Urea_cycle" title="Template:Urea cycle">urea cycle</a>
<ul>
<li><a href="/wiki/Template:Urea_cycle_enzymes" title="Template:Urea cycle enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nucleotide_metabolism_enzymes" title="Template:Nucleotide metabolism enzymes">nucleotide</a>
<ul>
<li><a href="/wiki/Template:Nucleotide_metabolism_intermediates" title="Template:Nucleotide metabolism intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Disorders_of_TCA_and_ETC" title="Template:Disorders of TCA and ETC">Citric acid cycle and electron transport chain</a></li>
<li><a href="/wiki/Template:Glycoprotein_disorders" title="Template:Glycoprotein disorders">Glycoprotein</a></li>
<li><a href="/wiki/Template:Proteoglycan_disorders" title="Template:Proteoglycan disorders">Proteoglycan</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders">Fatty-acid</a></li>
<li><a href="/wiki/Template:Phospholipid_metabolism_disorders" title="Template:Phospholipid metabolism disorders">Phospholipid</a></li>
<li><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism">Cholesterol and steroid</a></li>
<li><a href="/wiki/Template:Eicosanoid_metabolism_disorders" title="Template:Eicosanoid metabolism disorders">Eicosanoid</a></li>
<li><a href="/wiki/Template:Amino_acid_metabolic_pathology" title="Template:Amino acid metabolic pathology">Amino acid</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism">Purine-pyrimidine</a></li>
<li><a href="/wiki/Template:Heme_metabolism_disorders" title="Template:Heme metabolism disorders">Heme metabolism</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1226
CPU time usage: 0.287 seconds
Real time usage: 0.367 seconds
Preprocessor visited node count: 1799/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 62778/2097152 bytes
Template argument size: 1587/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 2/500
Lua time usage: 0.080/10.000 seconds
Lua memory usage: 2.98 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  281.840      1 - -total
 29.18%   82.240      1 - Template:Infobox_disease
 28.03%   79.012      1 - Template:Reflist
 24.82%   69.956      1 - Template:Infobox
 13.43%   37.847      1 - Template:Cn
 12.99%   36.598      2 - Template:Fix
 12.85%   36.211      5 - Template:Cite_journal
 11.69%   32.950      4 - Template:Category_handler
 11.51%   32.430      1 - Template:Lipidemias
 10.46%   29.481      3 - Template:Navbox
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:1593643-0!*!0!!en!4!* and timestamp 20150711063220 and revision id 670630179
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Hyperlipidemia&amp;oldid=670630179">https://en.wikipedia.org/w/index.php?title=Hyperlipidemia&amp;oldid=670630179</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Lipid_disorders" title="Category:Lipid disorders">Lipid disorders</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Pages_containing_cite_templates_with_deprecated_parameters" title="Category:Pages containing cite templates with deprecated parameters">Pages containing cite templates with deprecated parameters</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2014" title="Category:Articles with unsourced statements from October 2014">Articles with unsourced statements from October 2014</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_June_2012" title="Category:Articles with unsourced statements from June 2012">Articles with unsourced statements from June 2012</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hyperlipidemia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hyperlipidemia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Hyperlipidemia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Hyperlipidemia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Hyperlipidemia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Hyperlipidemia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Hyperlipidemia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Hyperlipidemia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Hyperlipidemia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Hyperlipidemia&amp;oldid=670630179" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Hyperlipidemia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1079120" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Hyperlipidemia&amp;id=670630179" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Hyperlipidemia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Hyperlipidemia&amp;oldid=670630179&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Hyperlipidemia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%81%D8%B1%D8%B7_%D8%B4%D8%AD%D9%85%D9%8A%D8%A7%D8%AA_%D8%A7%D9%84%D8%AF%D9%85" title="فرط شحميات الدم – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Hiperlip%C3%A8mia" title="Hiperlipèmia – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Hyperlipoprotein%C3%A4mie" title="Hyperlipoproteinämie – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Hiperlipidosis" title="Hiperlipidosis – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%87%DB%8C%D9%BE%D8%B1%D9%84%DB%8C%D9%BE%DB%8C%D8%AF%D9%85%DB%8C" title="هیپرلیپیدمی – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Hyperlip%C3%A9mie" title="Hyperlipémie – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EA%B3%A0%EC%A7%80%ED%98%88%EC%A6%9D" title="고지혈증 – Korean" lang="ko" hreflang="ko">한국어</a></li><li class="interlanguage-link interwiki-hi"><a href="//hi.wikipedia.org/wiki/%E0%A4%B9%E0%A4%BE%E0%A4%87%E0%A4%AA%E0%A4%B0%E0%A4%B2%E0%A4%BF%E0%A4%AA%E0%A4%BF%E0%A4%A1%E0%A4%BF%E0%A4%AE%E0%A4%BF%E0%A4%AF%E0%A4%BE" title="हाइपरलिपिडिमिया – Hindi" lang="hi" hreflang="hi">हिन्दी</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Iperlipoproteinemia" title="Iperlipoproteinemia – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%94%D7%99%D7%A4%D7%A8%D7%9C%D7%99%D7%A4%D7%99%D7%93%D7%9E%D7%99%D7%94" title="היפרליפידמיה – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Hiperlipidemia" title="Hiperlipidemia – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%93%D0%B8%D0%BF%D0%B5%D1%80%D0%BB%D0%B8%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D1%8F" title="Гиперлипидемия – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Hyperlipidemi" title="Hyperlipidemi – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-te"><a href="//te.wikipedia.org/wiki/%E0%B0%B9%E0%B1%88%E0%B0%AA%E0%B0%B0%E0%B1%8D%E2%80%8C_%E0%B0%B2%E0%B0%BF%E0%B0%AA%E0%B0%BF%E0%B0%A1%E0%B1%86%E0%B0%AE%E0%B0%BF%E0%B0%AF%E0%B0%BE" title="హైపర్‌ లిపిడెమియా – Telugu" lang="te" hreflang="te">తెలుగు</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B9%84%E0%B8%82%E0%B8%A1%E0%B8%B1%E0%B8%99%E0%B9%83%E0%B8%99%E0%B9%80%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%94%E0%B8%AA%E0%B8%B9%E0%B8%87" title="ไขมันในเลือดสูง – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E9%AB%98%E8%84%82%E8%A1%80%E7%97%87" title="高脂血症 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1079120#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 9 July 2015, at 05:03.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Hyperlipidemia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":113,"wgHostname":"mw1042"});
}</script>
	</body>
</html>
